Bromodomain inhibitor I-CBP112 breaks multidrug resistance conferred by overexpression of ABC transporters in cisplatin-resistant triple negative breast cancer

FEBS OPEN BIO

WILEY

1. [LIDER/22/0122/L-10/18/NCBR/2019]